| View |
|
DR-XY49118
|
Vancomycin (as hydrochloride)
|
Vansafe-CP
|
500 mg
|
Powder for Solution for Intravenous Infusion
|
Antibacterial (Glycopeptide)
|
VHB Medi Sciences Limited
|
India
|
Initial
|
28 June 2024
|
28 June 2029
|
| View |
|
DRP-15340
|
Paracetamol
|
Lifegesic OD
|
100 mg/mL
|
Suspension (Oral Drops) (Strawberry Flavor)
|
Analgesic/Antipyretic
|
Azine Healthcare Pvt., Ltd.
|
India
|
Initial [OTC]
|
25 June 2024
|
25 June 2029
|
| View |
|
DRP-15362
|
Paracetamol
|
Lifegesic
|
125 mg/5 mL
|
Oral Suspension (Strawberry Flavor)
|
Analgesic/Antipyretic
|
Azine Healthcare Pvt., Ltd.
|
India
|
Initial [OTC]
|
27 June 2024
|
27 June 2029
|
| View |
|
DRP-15361
|
Paracetamol
|
Lifegesic-250
|
250 mg/5 mL
|
Oral Suspension (Strawberry Flavor)
|
Analgesic/Antipyretic
|
Azine Healthcare Pvt., Ltd
|
India
|
Initial [OTC]
|
27 June 2024
|
27 June 2029
|
| View |
|
DRP-15341
|
Vancomycin (as hydrochloride)
|
Vanconov 1000
|
1g
|
Powder for Injection (IV Infusion)
|
Antibacterial (Glycopeptide)
|
Swiss Parenterals Ltd.
|
India
|
Initial [Re-application]
|
25 June 2024
|
25 June 2029
|
| View |
|
BR-1484
|
Eptacog alfa (activated)
|
NovoSeven RT
|
1 mg
|
Powder for Solution for Injection (IV)
|
Blood Coagulation Factor
|
Novo Nordisk A/S
|
Denmark
|
Initial (Reapplication)
|
01 July 2024
|
01 July 2029
|
| View |
|
DRP-15388
|
Irbesartan
|
Irbesaph-300
|
300 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (Re-application)
|
02 July 2024
|
02 July 2029
|
| View |
|
DRP-15389
|
Irbesartan
|
Irbesaph-150
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (Re-application)
|
02 July 2024
|
02 July 2029
|
| View |
|
DRP-8482
|
Rosuvastatin (as Calcium)
|
ROZTIN-20
|
20 mg
|
Film-Coated Tablet
|
Antihypercholesterolemia (HMG-CoA Reductase Inhibitor)
|
GRACURE PHARMACEUTICAL LTD.
|
India
|
Renewal
|
16 November 2023
|
15 January 2029
|
| View |
|
DRP-14369
|
dl-alpha Tocopheryl Acetate (Vitamin E)
|
EMINA-200
|
200 I.U
|
Softgel Capsule
|
Vitamin
|
OCEAN HEALTHCARE PVT. LTD.
|
India
|
Initial
|
30 August 2023
|
30 August 2028
|
| View |
|
DRP-14389
|
Furosemide
|
Ferobles
|
10 mg/mL (20 mg/2mL)
|
Solution For Injection
(I.V./I.M.)
|
Diuretic (Sulfonamide)
|
Makcur Laboratories Limited
|
India
|
Initial
|
31 August 2023
|
31 August 2028
|
| View |
|
DRP-15239
|
Enzalutamide
|
Allutamide
|
40 mg
|
Softgel Capsule
|
Anti-androgen
|
Lotus Pharmaceutical Co., Ltd. (Nantou Plant)
|
Taiwan
|
Renewal
|
11 June 2024
|
18 July 2027
|
| View |
|
DRP-9033-05
|
Levetiracetam
|
Julitam
|
100mg/mL
|
Oral Solution
|
Antiepileptic
|
Hetero Labs Limited
|
India
|
CLIDP Conversion
|
22 March 2023
|
20 August 2025
|
| View |
|
DRP-14836-01
|
Cloxacillin (as sodium)
|
None
|
500 mg
|
Capsule
|
Antibacterial (Beta-lactamase resistant penicillin)
|
Medico Remedies Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
18 January 2029
|
| View |
|
DRP-14853-02
|
Metformin Hydrochloride
|
None
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
24 June 2024
|
26 May 2025
|
| View |
|
DRP-15107-1
|
Gliclazide
|
Glizen 60
|
60 mg
|
Modified-Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
23 June 2024
|
20 December 2028
|
| View |
|
DRP-15228-01
|
Acetylcysteine
|
Mucocystein
|
600 mg
|
Effervescent Tablet
|
Mucolytic / Antidote
|
Vovantis Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 June 2024
|
29 April 2026
|
| View |
|
DRP-1551-02
|
Docusate Sodium
|
Audiwax
|
5 mg/mL (0.5%)
|
Ear drops
|
Ceruminolytic
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 June 2024
|
21 July 2029
|
| View |
|
DRP-2240-01
|
Paclitaxel
|
Taxelbene
|
6 mg/mL (260 mg/43.3 mL)
|
Solution for Intravenous Infusion
|
Antineoplastic (Taxane)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
24 June 2024
|
04 June 2025
|
| View |
|
DRP-2347-05
|
Ambroxol Hydrochloride
|
Broxygen
|
6 mg/mL
|
Syrup (Oral Drops)
|
Mucolytic
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
06 August 2026
|